Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pain Induced by m-Cresol as Preservative
Sponsor: Medical University of Vienna
Summary
Preservatives such as m-Cresol are essential components in many subcutaneously injected medications, including insulin or human growth hormone, to prevent bacterial growth. However, clinical reports have suggested that these preservatives may cause local discomfort or pain at the injection site, which can negatively impact treatment adherence. While m-Cresol is widely used, its direct contribution to injection-site pain has not yet been investigated in a prospective clinical trial. This study aims to investigate whether subcutaneous injection of m-Cresol at concentrations commonly used in clinical practice (0.1% and 0.25%) cause significantly more pain than a preservative-free control solution. In a randomized, double-blind crossover design, healthy volunteers will receive three separate injections in a belly fold. Participants will rate their pain every 5 seconds until it subsides. The findings will help determine if m-Cresol is a primary source of injection-site pain and could lead to the development of more comfortable drug formulations.
Official title: Pain Induced by m-Cresol as Preservative - A Randomised Controlled Crossover-Trial in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
18
Start Date
2026-05-25
Completion Date
2026-06-08
Last Updated
2026-05-22
Healthy Volunteers
Yes
Conditions
Interventions
m-Cresol 0.1%
A preservative administered subcutaneously at 0.1%, a common concentration used in medicines.
m-Cresol 0.25%
A preservative administered subcutaneously at 0.25%, a common concentration used in medicines.
Control Solution
A control solution administered subcutaneously.